Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,924.06 ($23.49) and traded as high as GBX 2,064 ($25.20). Hikma Pharmaceuticals shares last traded at GBX 2,062 ($25.18), with a volume of 345,386 shares trading hands.
Hikma Pharmaceuticals Price Performance
The company has a market cap of £4.50 billion, a PE ratio of 3,116.92, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The business has a 50 day moving average of GBX 1,927.95 and a 200 day moving average of GBX 1,924.78. The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27.
Hikma Pharmaceuticals Company Profile
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- What is the Euro STOXX 50 Index?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is the Shanghai Stock Exchange Composite Index?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- ETF Screener: Uses and Step-by-Step Guide
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
